Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels

scientific article published in April 2003

Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9149(03)00133-4
P698PubMed publication ID12686357

P2093author name stringYuji Hara
Akiyoshi Ogimoto
Jitsuo Higaki
Tomoaki Ohtsuka
Yuji Shigematsu
Hideyuki Saeki
Mareomi Hamada
P2860cites workEffect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathyQ32054917
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodelingQ33895464
Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathyQ43957432
Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenalineQ48512336
Differential gene expression of extracellular matrix components in dilated cardiomyopathy.Q52522346
A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureQ59599298
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitroQ73919594
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathyQ74561892
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectdilated cardiomyopathyQ283656
carvedilolQ412534
Idiopathic dilated cardiomyopathyQ63878253
P304page(s)1024-7, A8
P577publication date2003-04-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleSerum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels
P478volume91

Reverse relations

cites work (P2860)
Q46731252Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary
Q46533625Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy
Q37308645Matrix metalloproteinases: drug targets for myocardial infarction
Q47960038Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study
Q37219211Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure
Q27003263The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases
Q46699519Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality

Search more.